Shamzah Araf, Haematology Registrar, Barts Health NHS Trust
Arzhang Ardavan, Professor of physics, No affiliation
Pauline Boyle, King’s College London (KCL)
Sridhar Chaganti, Consultant Haematologist, Queen Elizabeth Hospital Birmingham
Stavroula Chante, Nurse, Queen Elizabeth Hospital Birmingham
Laura Clifton-Hadley, Trials Group Leader, University College London (UCL)
Graham Collins, Oxford University Hospitals NHS Foundation Trust
Richard A Cowan, Consultant/Director of Education, Christie NHS Foundation Trust
Thomas Cummin, Clinical Research Fellow/ Specialist Registrar Haematology, University of Southampton
David Cutter, Consultant Clinical Oncologist and Clinical Research Fellow, Oxford University Hospitals NHS Foundation Trust
Caroline Dalton, Research Programme Manager, Cancer Research UK (CRUK)
Paul Fields, Consultant Haematologist, Guy’s and St Thomas’ NHS Foundation Trust
Jude Fitzgibbon, Professor of Personalised Cancer Medicine, Queen Mary University of London
Christopher Fox, Consultant Haematologist, Nottingham University Hospitals NHS Trust
Daniel Hodson, Honorary Consultant Haematologist, University of Cambridge
Karen Hylton, Acting Research Delivery Manager, NIHR Division 1, NIHR Clinical Research Network – West Midlands
Tim Illidge, Clinical Oncologist Professor of Targeted Therapy & Oncology, Head of Division of Cancer Sciences, University of Manchester
Kim Linton, Honorary Consultant in Medical Oncology, University of Manchester
Pam McKay, NHS Greater Glasgow and Clyde
Andrew McMillan, Consultant Haematologist, Nottingham University Hospitals NHS Trust
Tobias Menne, Newcastle upon Tyne Hospitals NHS Foundation Trust
Geetha Menon, Haematopathologist, Liverpool University Hospitals NHS Foundation Trust
Wendy Osborne, Consultant Haematologist, Newcastle upon Tyne Hospitals NHS Foundation Trust
Andrew Pettitt, Professor of Haematology Molecular and Clinical Cancer Medicine, University of Liverpool
Beth Phillips, Lymphoma Clinical Trials Fellow, University College London (UCL)
Dr John Riches, Clincial Scientist, Barts and The London School of Medicine and Dentistry
Katharine Anne Robinson, Consumer Rep Lymphoma CSG, No affiliation
Stephen Scowcroft, Head of Business Development, Lymphoma Action
Emma Searle, Clinical Lecturer and Honorary Consultant Haematologist, University of Manchester
Louise Stanton, Principal Medical Statistician, University of Southampton
Fatima Sulaiman, Head of Research, Blood Cancer UK
Victoria Warbey, PET Imaging/Radiology, NHS Greater Glasgow and Clyde
